base recent survey conf call take cut model
ew alc main assumpt sharp fall
non-essenti procedur capital-expenditure revenu follow slow recoveri
year assum hit revenu flow
oper incom net hit ep new
model price target includ
first cut take number due forecast impact
medic technolog compani matrix revenu exposur procedur
capital-expenditure defer might benefit hospit hospit
physician physician decision-mak base covid impact
respect region long situat persist trajectori
recoveri impact earn determin compani choos moder
expens view temporari impact sever
imposs know weve tri inform survey work call
weve done compani clinician stakehold real-tim view
impact link replay survey
make assumpt made sever key assumpt new forecast
impact deferr procedur capital-expenditure deepest earli
procedur initi hit wors capital-expenditure procedur recov back
half earli capital-expenditure take longer compani moder
expens modestli given short-term natur impact revenu
lost revenu flow oper incom model month
month impact differ revenu procedur capital-expenditure overlaid
compani respect exposur notabl trajectori recoveri area
find debat convers cross current clinicians/hospit
want make lost revenu patient need care off-set question
economi patient willing go hospit take vaccin
thing normal
deep cut notabl dispar valuat new model
ew alc attach net averag hit
ep summari chang shown base new
estim valuat rang ew notabl trade
three trade near pariti prior current
crisi see less hit ep rel valuat stand
new price target equal imprecis exercis cut number adjust
price target gener roll forward multipl
make chang rate note upsid seem best
least
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
summari chang
mm estim exclud one-tim item
ep ep exclud amort begin
pleas see import disclosur inform page report
forecast impact medic technolog compani matrix revenu exposur procedur defer
might benefit hospit hospit physician physician decision-mak base covid
impact respect region long situat persist trajectori recoveri volum also
inform top-line impact impact earn determin compani choos moder expens
view temporari impact final also overlay compani respect capit structur restrict
sever imposs know weve tri inform survey work call weve done compani
clinician stakehold real-tim view impact
situat remain fluid hospit provid curtail normal practic prepar treat covid patient sever
peopl spoke report hospit censu typic run howev though degre non-essenti
procedur cancel variesit report call littl much remain flux
hospit deferr low like increas convers report area
restrict non-essenti procedur relax anticip wave covid patient yet hit certain procedur
also continu done includ cancer treatment emerg case across multipl disciplin weve heard orthoped
trauma infect risk fractur revis cardiolog pci emerg case high risk tavr vt storm heart block ep
capital-expenditure spend anoth wrinkl commentari hospit suggest purchas plan way like continu
also spend could depress period hospit go lean period given depress high acuiti
trajectori recoveri area find debat convers cross current clinicians/
hospit want make lost revenu patient need care off-set question economi patient willing
go hospit take vaccin thing normal physician hospit execut comment
vast major defer case done note number physician hand deck
situat back log clear rel quick period weve heard quickli time delay one
month delay clear one month time long gener given slack system willing clinician
institut recov lost revenu would expect thing normal rel quickli one caveat procedur
base referr fewer patient get diagnos period fewer fill funnel
adjust model weve taken consider establish monthli framework reflect impact deferr sale
capital-expenditure forecast quickli recov fulli acknowledg first cut number go wrong
start
exhibit summari ep revis
pleas see import disclosur inform page report
exhibit summari impact recoveri
exhibit summari valuat chang
pleas see import disclosur inform page report
cap mnev mnticker move sinc compani cap-exdefer procedure-basedjanfeb maraprmayjunjulaugsepoctnovdecprocedur epscurr price-to-earnings price-to-earnings pe pt new ptupsid ptprior equiti research
replay inform prior call date replay first three call dial
intern caller use confer id
dr claudett lajam nyu orthoped surgeon confer id
dr paul teirstein scripp clinic intervent cardiologist confer id
hospit cfo valley medic nj new york-presbyterian/queen hospit
dr joel buchalt somer orthoped group orthoped surgeon link replay
dr suneet mittal electrophysiologist valley heart vascular institut nj
link replay
dr alan bulbin infecti diseas physician st franci hospit roslyn ny
link replay
survey show begin impact us procedur volum link note
follow-up survey show impact procedur grown much deeper
link note
pleas see import disclosur inform page report
cut abbott balanc provid offset pt rel
unscath recent sell med-tech share period feb though april ihi
almost better perform owe balanc busi includ nutrit epd diagnost
med-tech commentari suggest rel good perform nutrit epd crisi thu far med-tech
diagnost like go see signific impact diagnost off-set covid test rapid molecular
add quarter capac continu use seem howev offset diagnost
fewer standard test done well convers manufactur capac within rapid test off-set upsid
med-tech nearli compani revenu procedur delay diabet like saw earli stock
new start libr could stall height crisi
taken total lower prior prior
repres top-lin ep reduct net covid impact
pleas see import disclosur inform page report
report expens foreign exchang gain incom expens tax equiti research
alcon alc buy take cut ep cut ep covid headwind pt prior alc among
first univers factor relat headwind forecast exit call feb time
predominantli impact co china busi mostli within surgic given larger mix exposur revis guidanc
call top-lin ep impact base februari trend track intern expect due
postpon cancel cataract procedur sinc impact grown global earli guidepost exposur
seem grossli low check past sever week hospit administr varieti surgeon suggest
cataract surgeri among top list procedur consid non-urg abl delay accordingli
model similar pressur across remaind compani iol busi gradual recoveri baked-
begin total volum dollar still last year trough level also bake
drop-off equip within surgic factor pressur lasik cataract upgrad cycl vision
also model pressur contact lens albeit less pure elect procedur factor drop new fit set mani
us optometri practic oper reduc hour shutter area shelter-in-plac order assum
pressur off-set telemedicin visit facilit contact len reorder
taken total lower prior prior
repres top-lin ep reduct net covid impact
pleas see import disclosur inform page report
edecmarjunsepdecdecmarjunsepdecdecdectot growth good gross margin oper oper oper incom oper margin financi incom loss tax expens rate incom pre-tax oper incom incom ep fulli y/ynmnmnmnmnmnmnmnmnmnmnmnmshar outstand outstand ebitda calcul adj oi ebitda margin equiti research
cut nearli everyth defer pt boston wors
med-tech compani offer procedur delay period time stent tavr
watchman icd endoscopi push bsx issu compound rel high leverag compani
requir compani achiev coverag year-end sens compani like trip cut
cash flow simpli high impact like bad like increas rate though flux
calculu bsx exposur base revenu procedur base delay compani recent
withdrew guidanc though note would low singl digit report organ basi
taken total lower prior prior
repres top-lin ep reduct net covid impact
pleas see import disclosur inform page report
edec margin ensessel gener administr revenu revenu oper ens oper incom margin ex-amort incom incom tax net ep share equiti research
ew cut tavr prove resili pt confer call intervent
cardiologist hospit administr point disrupt tavr procedur could still get doneon doc put
impact tavr off-set seem co-morbid patient suffer whether wait tavr could
lead increas mortal risk tavr like push patient whole less sick tavr also
one type procedur come back urgenc
taken total lower prior prior
repres top-lin ep reduct net covid impact
pleas see import disclosur inform page report
total growth gross ensestot oper oper oper expens inc incom incom tax ens incom growth dilut equiti research
buy lower headwind pt prior mostli
neg implic mani segment portfolio face vari degre pressur off-set demand surg
select offer account global revenu use base headwind side major sbu
see vari level pressur within cvg cardiac rhythm heart failur divis everi divis like see headwind
pacemak crt-d cardiac monitor coronari peripher lvad structur heart within mitg demand surg
ventil monitor off-set pressur across surgic innov divis surgic stapler vessel seal wound
closur given pushout elective/non-urg surgeri hernia repair low-risk prostat low risk bariatr within rtg vast
major spine neuro delay estim revenu defer non-essenti
tailwind side drive increas uptak icu mechan ventil puritan bennet bedsid patient monitor
capnographi solut diabet suppli among mechan ventil see pronounc demand surg
howev demand capac remain low even expand still produc less per week
per month
taken total lower prior prior
repres top-lin ep reduct net covid impact
pleas see import disclosur inform page report
eaprjuloctjanapraprjuloctjanapraprjuloctjanaprapraprtot oper oper non-oper incom loss tax control net dilut share equiti research
cut nearli everyth defer capit pt
offset deferr revenu compani anti-infect product like see strong demand nearli everyth els
pressur beyond disrupt busi knee-deep acquisit fate progress
cash consider plu debt transact debat express strong support strateg merit
deal financi side never strong suit deal consider us find
debt like cover given fall ebitda year oner support one assum current disrupt
short-term compani recent withdrew guidanc
taken total lower prior prior
repres top-lin ep reduct net covid impact
pleas see import disclosur inform page report
growth good oper expens incom ex tax incom incl min incom ep share equiti research
cut orthoped deferr pt zimmer find
unenvi posit nearli revenu deferr outsid trauma like see declin peopl
social distanc hip knee spine sport med extrem defer univers call also univers
procedur come back patient stage need orthoped intervent pain unlik
go away also trade lowest multipl larg cap med-tech name
taken total lower prior prior
repres top-lin ep reduct net covid impact
pleas see import disclosur inform page report
edec margin oper incom expens tax incom adjust ep ep share equiti research
pt deriv ep outlook
diabet growth sustain libr product
diabet growth sustain libr cycl
structur heart growth sustain mitraclip
lab growth sustain hsd alin roll-out
adj om reach exit combo mix
leverag gain deal synergi
structur heart growth sustain mitraclip
lab growth sustain low dd alin roll-out
adj om surpass exit combo mix
leverag gain deal synergi
large-scal next year add anoth
growth vertic accret near-term
pt deriv ep outlook
diabet growth deceler mute
libr adopt upon us clearanc libr
secur icgm design
structur heart growth deceler
lab growth deceler msd slow
limit alin adopt assay clearanc
adj om remain rang bound slow
large-scal next year prove dilut
top-lin growth ep near-term
pt deriv ep outlook
buy thesi base maintain above-peer-
averag top-lin growth heel three key product
launch libr diabet mitraclip structur heart
alin lab next year
work differenti front deep-
dive/survey work/channel check cgm space
support libr thesi deep-dive/survey work/
channel check structur heart space support
mitraclip thesi
us commerci launch freestyl libr
on-going us clearanc alin diagnost assay
launch triclip tendyn
re-launch php clinic program
pleas see import disclosur inform page report
estim exclud one-tim item
compound-annual-growth-rate surgic driven launch panoptix
implant vitreoretin equip
compound-annual-growth-rate contact lens support
gm expans vision
larg scale initi lrp
acceler debt servic share buyback near-
compound-annual-growth-rate surgic driven launch panoptix
assum share gain at-iol
compound-annual-growth-rate contact lens support
assum share gain
gm expans vision
one larg scale transact initi lrp
excess capit post alloc share buyback
compound-annual-growth-rate surgic limit uptak
panoptix due cost/reimburs barrier
compound-annual-growth-rate contact lens limit uptak
share loss daili
delay vision manufactur beyond
larg scale initi lrp prove
acceler debt servic share buyback near-
buy thesi predic potenti signific
ep acceler initi lrp
differenti base proprietari
survey work inclus cataract surgeon
explor demand panoptix consum len
explor demand
driver ep acceler outlook better
industri fundament ophthalmolog versu
at-iol revenu upsid sihi
daili len margin expans vision
manufactur modern non-oper
pleas see import disclosur inform page report
stabl end market reinvigor product
offer yield good continu strong
growth
continu margin expans per
moder ramp us lotu tavr launch start
reach market share
embol protect gain traction tavr claret
pt base compani ep
upper-end peer given best-in-class growth
lotu adopt exce expect tavr
prove bigger expect
upsid margin expans target particularli
opportun meaning
uptick de market strong uptak new
faster growth io btg
upsid base compani ep
slower adopt lotu post us launch
failur realiz margin gain
market deterior and/or share loss within core
de franchis
pt base compani ep
boston perform hing continu strength
core market launch lotu pipelin contribution/
trial updat growth new area like io push
compani sustain top-lin growth
level growth unpreced among large-cap
watchman warfarin-inelig
pleas see import disclosur inform page report
